The plaintiffs accuse the defendants of breach of fiduciary duty, issuing false and misleading proxy statements, wasting corporate assets and unjust enrichment since December 2021.
November 29, 2023 at 06:35 PM
3 minute read
Litigation Reporter
BioXcel Therapeutics faces a shareholder derivative lawsuit over allegations that its clinical trials for a neurological medicine did not follow proper protocols.
The plaintiffs also allege in their complaint that BioXcel’s principal investigator fabricated emails.
Presented by BigVoodoo
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Credit: Tamara/Adobe Stock
